Childhood Cancer Therapeutic Catalyst
Funds collaborative research to rapidly advance early-stage drug discovery for childhood and young people’s cancers, supporting translation of promising science into new therapeutic options.
Funder: Cancer Research UK
Due Dates: October 1, 2026: Expression of interest deadline (October 2026)
Funding Amounts: Up to £250,000 per project for up to 18 months.
Summary: Supports collaborative projects to accelerate early-stage drug discovery for childhood and young people's cancer, translating research into novel therapeutics.
Description
This scheme is designed to accelerate the translation of discovery research into novel therapeutics for children and young people with cancer. It funds collaborative projects between academic researchers and Cancer Research Horizons drug discovery laboratories, providing both financial support and expert guidance to de-risk early-stage therapeutic projects. The aim is to position promising discoveries for further drug development, funding, or partnering, with a strong focus on projects likely to deliver new therapeutic options for childhood cancers.
